Yamasaki H, Omori Y, Zaidan-Dagli M L, Mironov N, Mesnil M, Krutovskikh V
Unit of Multistage Carcinogenesis, International Agency for Research on Cancer, Lyon, France.
Cancer Detect Prev. 1999;23(4):273-9. doi: 10.1046/j.1525-1500.1999.99037.x.
During multistage carcinogenesis, the functions of several key genes involved in cell growth control must be damaged. Such genes include not only those involved in cell cycle control of individual cells, but also those involved in the coordination of cell growth throughout a given tissue through cell-cell communication. The most intimate form of intercellular communication is mediated by gap junctions. Gap junctional intercellular communication (GJIC) is known to transfer small water soluble molecules, including cAMP and IP3, from the cytoplasm of one cell to that of its neighbors; the growth of a given GJIC-associated cell is thus kept in check by other GJIC-connected cells. Most tumor cells have a reduced ability to communicate among themselves and/or with surrounding normal cells, confirming the importance of intact GJIC in growth control. When connexin (gap junction protein) genes are transfected into such cells, normal cell growth control is often recovered. Certain dominant-negative mutant connexin genes can reverse such tumor suppression. While these results suggest that connexin genes form a family of tumor suppressor genes, so far we have found no connexin gene mutations in human tumors; only two connexin gene mutations were found in chemically induced rat tumors. On the other hand, our recent studies suggest that connexin genes may be inactivated by hypermethylation of their promoter regions, suggesting that epigenetic inactivation of connexin genes may be a mechanism of GJIC disturbance in certain tumors. However, in many tumor cells connexins are normally expressed but aberrantly localized. The mechanisms of aberrant localization of connexins include lack of an appropriate cell-cell recognition apparatus and aberrant phosphorylation of connexins. These results suggest that GJIC disorders may occur not only because of aberrant expression of connexin genes themselves, but also as a result of disruption of various control mechanisms of the protein functions.
在多阶段致癌过程中,参与细胞生长控制的几个关键基因的功能必定会受损。这些基因不仅包括那些参与单个细胞细胞周期控制的基因,还包括那些通过细胞间通讯参与给定组织中细胞生长协调的基因。细胞间通讯最密切的形式是由间隙连接介导的。已知间隙连接细胞间通讯(GJIC)可将包括cAMP和IP3在内的小的水溶性分子从一个细胞的细胞质转移到其相邻细胞的细胞质;因此,给定的与GJIC相关的细胞的生长受到其他与GJIC相连的细胞的抑制。大多数肿瘤细胞自身之间和/或与周围正常细胞之间的通讯能力降低,这证实了完整的GJIC在生长控制中的重要性。当将连接蛋白(间隙连接蛋白)基因转染到这类细胞中时,正常的细胞生长控制常常得以恢复。某些显性负性突变连接蛋白基因可逆转这种肿瘤抑制作用。虽然这些结果表明连接蛋白基因构成了一个肿瘤抑制基因家族,但到目前为止,我们在人类肿瘤中未发现连接蛋白基因突变;在化学诱导的大鼠肿瘤中仅发现两个连接蛋白基因突变。另一方面,我们最近的研究表明,连接蛋白基因可能因其启动子区域的高甲基化而失活,这表明连接蛋白基因的表观遗传失活可能是某些肿瘤中GJIC紊乱的一种机制。然而,在许多肿瘤细胞中,连接蛋白通常表达但定位异常。连接蛋白定位异常的机制包括缺乏适当的细胞间识别装置和连接蛋白的异常磷酸化。这些结果表明,GJIC紊乱不仅可能由于连接蛋白基因本身的异常表达,还可能是由于蛋白质功能的各种控制机制的破坏所致。